Malecare Sept. 2013 Teleconference

Submitted by Matt on Thu, 2013-09-12 00:52

Malecare.org: "Understanding the New Tests For Prostate Cancer"
Thursday, September 12, 2013 at 6PM EDT

1- An overview of the new tests becoming available for men regarding prostate cancer
2- A discussion about these new tests and their role in current treatment choices.
3- Q&A
Dial in at 1.800.868.1837 or direct dial 1.404.920.6440
conference code 537349# (don't forget to press #)

Questions to be covered include:
1. How do researchers use genetics to better understand prostate cancer?
Background/overview on genetics and genetic studies in common disease.
2. How is one's risk of prostate cancer currently predicted?
Prediction of prostate cancer - emphasis on utility of family history
3. Can genetics be used to improve prostate cancer prediction?
iCOGs study, genetic correction of PSA values
4. How does genomic analysis of tumor inform treatment? (briefly)
Genetic sequencing of tumors; Biomarker-based (non-DNA) diagnostics

(Dr. Moul, originally scheduled as a speaker, will be rescheduled for early 2014.)

Speakers:

1. Daniel Lieber, PhD, is a graduate of Harvard University’s Systems Biology PhD program. He worked in Vamsi Mootha’s laboratory, where his thesis was entitled: “Computational and Experimental Approaches for Evaluating the Genetic Basis of Mitochondrial Disorders.” He was selected for the National Science Foundation Graduate Research Fellowship in 2010. He graduated magna cum laude from Princeton University with an AB in Molecular Biology and a certificate in Finance. He is a member of the American Society of Human Genetics and a student member of the American Academy of Neurology.

2. Steve Hershman, PhD, MS, MSE, is a graduate of the Systems Biology PhD program at Harvard University. His thesis, “Personal Genomics and Mitochondrial Disease”, describes efforts to identify causal genetic lesions in patients with mitochondrial disease and the development of web-based tools to explore genetic data. His research has been published in the journals Science Translational Medicine, Cell Metabolism and Nucleic Acids Research. Previously Steve earned a Bachelor’s degree in Biochemistry summa cum laudeand Masters’ degrees in Chemistry and Computer & Information Sciences from the University of Pennsylvania.

3. Joel Nowak, MSW, MS
Director, Advocacy and Advanced Stage Disease
Malecare Cancer Support

Like0 Dislike0